UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 16, 2002 HERMAN MILLER, INC. (Exact name of Registrant as specified in its charter) Michigan 001-15141 38-0837640 (State or Other Jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) 855 E. Main Avenue, Zeeland, Michigan 49464 (Address of Principal Executive Offices) (Zip Code) 616-654-3000 (Registrant's Telephone Number, Including Area Code) Not Applicable (Former Name or Former Address, if changed Since Last Report)Item 5. Other Events On July 16, 2002, the Board of Directors of the Company appointed Douglas D. French as a director of the Company. Mr. French is the president and chief executive officer of Ascension Health, the nation's largest not for profit health system. Mr. French has served as CEO of Ascension Health since January 1, 2001. Prior to that time and since 1998, he served as president and chief operating officer of Ascension Health.
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: July 19, 2002 HERMAN MILLER, INC. By /s/ James E. Christenson Its Secretary